Skip to main content

Find Clinical Trials

Home
Conditions
Astrocytoma IDH Mutant Grade 2

Clinical trial condition

Astrocytoma IDH Mutant Grade 2

Explore clinical trials studying Astrocytoma IDH Mutant Grade 2. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Astrocytoma IDH Mutant Grade 2 trial results

Not Yet Recruiting

Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma

NCT07712757

Conditions: Astrocytoma, Astrocytoma IDH Mutant Grade 2, Glioma, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

NCT07703436

Conditions: Astrocytoma IDH Mutant Grade 2, Astrocytoma IDH Mutant Grade 3, Glioma, +12 more
Locations: Not specified

View Trial Details